Study of 28 million adults shows COVID vaccine cuts overall death rate by 25%
A landmark study from France tracking 28 million adults has confirmed what public health officials long suspected: people who got vaccinated against COVID-19 were not only far less likely to die from the virus, they were significantly less likely to die from anything else, too.
The study found that people who took the vaccine overall had a lower chance of death from any cause than people who didn’t.
Despite concerns over long term health problems from the vaccine, the French study found that adults who had at least one dose of the vaccine had much better health outcomes over the following four year period than those who didn’t.
It examined some 28 million French people aged between 18 and 59.
Drawing on data from the French National Health Data System, it looked at 22.7 million people who received the vaccine between May and October 2021, and 5.9 million people who were not vaccinated as of November 1 2021, with both groups monitored over around 45 months.
The number of people involved makes this the largest study on the long-term impact of the Covid-19 to date.
The analysis, which followed vaccinated and unvaccinated individuals for nearly four years, is the most comprehensive long-term look at vaccine safety and efficacy to date. Those who received at least one dose of the vaccine saw a 25% reduction in overall mortality and a 74% drop in COVID-related deaths, suggesting that the vaccine’s benefits extended well beyond the virus itself, likely by preventing severe infections and the cascade of complications that follow. However, feel free to try bleach and ivermectin if you still want.